+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
From
From
From
Emphysema Treatment Global Market Report 2024 - Product Thumbnail Image

Emphysema Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Glomerulonephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Glomerulonephritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Nontuberculous Mycobacterial Infections Market 2024-2028 - Product Thumbnail Image

Nontuberculous Mycobacterial Infections Market 2024-2028

  • Report
  • December 2023
  • 177 Pages
  • Global
From
From
From
From
From
End Stage Renal Disease (ESRD) Drug Global Market Report 2024 - Product Thumbnail Image

End Stage Renal Disease (ESRD) Drug Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator